Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland.
about
Cost-effectiveness of biological treatment of ulcerative colitis - a systematic review.Cost-effectiveness of golimumab for the treatment of patients with moderate-to-severe ulcerative colitis in Quebec using a patient level state transition microsimulation.A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease.A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis.
P2860
Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cost-Effectiveness Analysis of ...... Ulcerative Colitis in Poland.
@ast
Cost-Effectiveness Analysis of ...... Ulcerative Colitis in Poland.
@en
type
label
Cost-Effectiveness Analysis of ...... Ulcerative Colitis in Poland.
@ast
Cost-Effectiveness Analysis of ...... Ulcerative Colitis in Poland.
@en
prefLabel
Cost-Effectiveness Analysis of ...... Ulcerative Colitis in Poland.
@ast
Cost-Effectiveness Analysis of ...... Ulcerative Colitis in Poland.
@en
P2860
P1433
P1476
Cost-Effectiveness Analysis of ...... Ulcerative Colitis in Poland.
@en
P2093
Ewa Stawowczyk
Paweł Kawalec
P2860
P304
P356
10.1371/JOURNAL.PONE.0160444
P407
P50
P577
2016-08-05T00:00:00Z